2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Finland Leader Award
2013 - Member of the National Academy of Sciences
2011 - Member of Academia Europaea
Member of the European Molecular Biology Organization (EMBO)
The scientist’s investigation covers issues in Angiogenesis, Lymphatic system, Vascular endothelial growth factor C, Vascular endothelial growth factor and Pathology. Her Angiogenesis research incorporates themes from Endothelial stem cell, Endothelium, Receptor tyrosine kinase and Cell biology. The concepts of her Lymphatic system study are interwoven with issues in Lymph and Lymph sacs, Lymphatic vessel, Lymphangiogenesis.
Her research investigates the link between Lymphangiogenesis and topics such as Immunology that cross with problems in Lymphedema. Her Vascular endothelial growth factor research is multidisciplinary, incorporating perspectives in Endocrinology and Growth factor. The various areas that Kari Alitalo examines in her Pathology study include Tumor progression and Circulatory system.
Her primary areas of investigation include Angiogenesis, Cell biology, Cancer research, Lymphatic system and Vascular endothelial growth factor C. Her studies deal with areas such as Endothelial stem cell, Vascular endothelial growth factor, Immunology, Receptor tyrosine kinase and Endothelium as well as Angiogenesis. Her Cell biology study incorporates themes from Receptor, Angiopoietin receptor and Molecular biology.
Her Cancer research research includes elements of Carcinogenesis, Cancer and Gene. Her biological study deals with issues like Lymphangiogenesis, which deal with fields such as Inflammation. Her Vascular endothelial growth factor C research integrates issues from Kinase insert domain receptor, Vascular endothelial growth factor B, Vascular Endothelial Growth Factor D, Vascular permeability and Vascular endothelial growth inhibitor.
Her main research concerns Lymphatic system, Lymphangiogenesis, Angiogenesis, Cell biology and Pathology. The study incorporates disciplines such as Lymph node, Lymphedema, Anatomy and Lymphatic vessel in addition to Lymphatic system. Her studies in Lymphangiogenesis integrate themes in fields like Vascular endothelial growth factor C, Inflammation, Immune system, Immunology and Lacteal.
Her Angiogenesis study combines topics in areas such as Endothelial stem cell and Vascular endothelial growth factor, Angiopoietin. Her work deals with themes such as Regulator and Receptor, Biochemistry, Paracrine signalling, which intersect with Cell biology. Her Pathology study combines topics from a wide range of disciplines, such as Reperfusion injury, Ischemia and Endothelium.
Kari Alitalo mainly investigates Lymphangiogenesis, Cell biology, Lymphatic system, Angiogenesis and Vascular endothelial growth factor C. Her work carried out in the field of Lymphangiogenesis brings together such families of science as Endothelial stem cell, Immunology, Pathogenesis, Progenitor cell and Receptor tyrosine kinase. Her Cell biology research includes themes of Vascular endothelial growth factor A, Endothelium, Autocrine signalling and Paracrine signalling.
To a larger extent, Kari Alitalo studies Pathology with the aim of understanding Lymphatic system. Her research integrates issues of Vascular endothelial growth factor B and Vascular endothelial growth factor, Angiopoietin in her study of Angiogenesis. Her Vascular endothelial growth factor C research integrates issues from Endocrinology, Growth factor, Lymphatic Endothelium and Anatomy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Holger Gerhardt;Matthew Golding;Marcus Fruttiger;Christiana Ruhrberg.
Journal of Cell Biology (2003)
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
V Joukov;K Pajusola;A Kaipainen;D Chilov.
The EMBO Journal (1996)
Molecular regulation of angiogenesis and lymphangiogenesis.
Ralf H. Adams;Kari Alitalo.
Nature Reviews Molecular Cell Biology (2007)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Mihaela Skobe;Thomas Hawighorst;David G. Jackson;Remko Prevo.
Nature Medicine (2001)
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.
Manfred Schwab;Kari Alitalo;Karl Heinz Klempnauer;Harold E. Varmus.
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.
Arja Kaipainen;Jaana Korhonen;Tuija Mustonen;Victor W. M. van Hinsbergh.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
Michael Jeltsch;Arja Kaipainen;Vladimir Joukov;Xiaojuan Meng.
Clinical applications of angiogenic growth factors and their inhibitors
Napoleone Ferrara;Kari Alitalo.
Nature Medicine (1999)
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
Marc G. Achen;Michael Jeltsch;Eola Kukk;Taija Mäkinen.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
Marika J Karkkainen;Paula Haiko;Kirsi Sainio;Juha Partanen.
Nature Immunology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: